How does Dexedrine (dextroamphetamine) compare with Adderall (mixed amphetamine salts) regarding potency, duration of action, dosing, and side effect profile?

Dexedrine vs Adderall: Clinical Comparison

Both Dexedrine (dextroamphetamine) and Adderall (mixed amphetamine salts) are essentially equivalent in efficacy for ADHD treatment, with Adderall providing slightly earlier onset but Dexedrine potentially causing more weight loss—choose based on duration needs and side effect tolerance rather than expecting meaningful differences in core symptom control.

Composition and Mechanism

Adderall contains a 3:1 ratio of dextroamphetamine to levoamphetamine (mixed salts including dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate) 111. Dexedrine contains only the dextro-isomer of amphetamine. Both work through dopamine and norepinephrine transporter inhibition, vesicular monoamine transporter 2 inhibition, and monoamine oxidase activity modulation 2.

Efficacy and Potency

The medications demonstrate comparable therapeutic effects for ADHD core symptoms:

• A head-to-head randomized trial found no significant difference in ADHD symptom response between dexamphetamine and methylphenidate over 12 months, with similar persistence rates (68% vs 56%, p=0.15) 3
• A direct comparison study showed all amphetamine formulations exhibited "robust efficacy versus placebo on nearly all measures" 4
• Both are first-line stimulant options with large effect sizes for reducing ADHD symptoms 2

Practical implication: Don't expect one to work better than the other for symptom control—if one fails at adequate dosing, switching to the other amphetamine formulation is unlikely to provide benefit.

Duration and Pharmacokinetics

Immediate-release formulations:

• Adderall IR: Earlier onset of effects, shorter duration (4-6 hours) 4
• Dexedrine IR: Comparable short duration
• Dexedrine Spansules (extended-release): Effects last 3-6 hours longer than immediate-release formulations, with sustained effects up to 12 hours but less robust morning effects 4

The key difference is that dextroamphetamine Spansules showed "more sustained effects that were present on a wider range of measures" including academic performance 4 hours post-dosing 4.

Dosing Considerations

Both medications follow similar dosing principles:

• Start low and titrate based on response
• Maximum doses typically 60 mg/day for immediate-release formulations (per Asian guidelines for amphetamines) 5
• Weight-based titration protocols are standard 3
• Long-acting formulations allow for individualized pharmacokinetic profiles 22

Side Effect Profile

Cardiovascular effects (identical for both):

• Systolic BP increase: 1.93 mmHg (95% CI 1.54-2.31)
• Diastolic BP increase: 1.84 mmHg (95% CI 1.51-2.16)
• Heart rate increase: 3.71 bpm (95% CI 3.27-4.14)
• These effects persist with chronic use (≥8 weeks) 6

Weight effects (KEY DIFFERENCE):

• Dexamphetamine causes significantly greater weight loss: -1.44 kg vs -0.31 kg at 3 months (p=0.005) 3
• Both cause statistically significant reductions in height and weight gain long-term 2

Common adverse effects (similar for both):

• Decreased appetite
• Sleep disturbances
• Headaches
• Irritability
• Stomach pain 22

Withdrawal rates: Amphetamines overall increase study withdrawal due to adverse effects (RR 2.69,95% CI 2.13-3.40; 4.3% absolute risk increase) 6

Abuse Potential

Critical caveat: Dexamphetamine and lisdexamfetamine (a dextroamphetamine prodrug) show "comparable potential for oral abuse"—the pharmacokinetic profile of lisdexamfetamine is "essentially identical to that of an equimolar dose of dexamphetamine administered 1 hour later" 7. Both Adderall and Dexedrine are Schedule II controlled substances with similar abuse liability.

Clinical Algorithm for Selection

Choose Adderall IR when:

• Rapid onset is critical
• Shorter duration coverage needed (4-6 hours)
• Weight loss is particularly concerning

Choose Dexedrine Spansules when:

• Extended coverage needed (up to 12 hours)
• Sustained afternoon/evening symptom control required
• Academic performance in afternoon is priority

Monitor in both cases:

• Pulse and blood pressure at each visit 22
• Height and weight regularly 2
• Suicidality and clinical worsening (though stimulants may actually decrease suicidal risk) 22

Common Pitfalls

• Don't switch between amphetamine formulations expecting different efficacy—they work through identical mechanisms 2
• Don't assume extended-release formulations provide overdose protection—linear dose-proportional pharmacokinetics persist at supratherapeutic doses 7
• Don't overlook the greater weight loss with dexamphetamine—this is clinically significant and requires closer monitoring 3
• Don't forget that alkalizing agents can prolong amphetamine exposure—counsel patients about antacids and dietary factors 7